NASDAQ NMS - GLOBAL MARKET · PULM
+0.00% · +$0.0000 · Vol 1.4K
Market closed · last close 4:00 PM ET · price as of 12:51:06 ET
Pulmatrix Inc

Pulmatrix Inc

Pharmaceuticals
$1.66
Card
Relationship Map

Veridion Score

BETALOW CONF · 5/6 factorsMethodology
PULM
Pulmatrix Inc
Sat Aug 8 · market closed · Markets closed · resumes Mon 9:30 ET
NEUTRAL

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

59/ 100
Veridion Score
NEUTRAL · LOW confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: LOW · 5/6 factors with data · Sat Aug 8 · market closed · Markets closed · resumes Mon 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is PULM moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading PULM catalysts
About Pulmatrix Inc
PHARMACEUTICAL PREPARATIONS
Listed since
2014
Employees
2
Country
US

Pulmatrix Inc is a biopharmaceutical company focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$1.68
Day high
$1.68
Day low
$1.66
Previous close
$1.66
52W high
$5.19
-68.02% from high
52W low
$1.19
12% of range
Market cap
$6.1M
EPS
$-0.4800
Beta
-0.26
Shares out
3.7M
Volume
1.4K
0.07× rel vol
Avg volume
18.6K
VWAP
$1.67
Price history computed in-house
1W
-4.60%
1M
-7.78%
3M
+27.98%
1Y
-67.28%
YTD
-25.56%
SMA 50 $1.59 · above
SMA 200 $2.42 · below
52W position 12%

PULM overview

Veridion Score
59
5 of 6 factors measured
Congress receipts
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around PULM.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading PULM Form 4 filings
Public disclosures

Congress activity in PULM

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for PULM in the cached public ledger.

Federal contracts

PULM contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for PULM in this window.
Lobbying spend

PULM lobbying filings, year to date.

Registered lobbying filings matched to Pulmatrix Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for PULM in this window.
Loading news for PULM
Analyst ratings
Sovereign unlock shows live analyst consensus for PULM.
Options
Sovereign unlock shows live options positioning for PULM.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.